Credit: Getty Images. Prevymis is a CMV DNA terminase complex inhibitor. The Food and Drug Administration (FDA) has approved the extended use of Prevymis ® (letermovir) from 100 to 200 days ...
Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.
Federal data indicate that over half the US population aged 6-46 years is infected with cytomegalovirus (CMV), typically spread through bodily fluids. Most people have mild or no negative effects from ...